查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球基因毒性測試市場-行業規模、份額、趨勢、機會和預測，2018-2028F 按成分、類型、應用和地區分析
市場調查報告書
商品編碼
1244115

全球基因毒性測試市場-行業規模、份額、趨勢、機會和預測，2018-2028F 按成分、類型、應用和地區分析

Genetic Toxicology Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component, By Type, By Application, By Region
出版日期: | 出版商: TechSci Research | 英文 115 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球基因毒性檢測市場預計在預測期內將出現令人矚目的增長。

這是由於人們對藥物發現以及針對各種疾病的新療法和療法的開發越來越感興趣。 此外，各種體外個性化藥物的使用率提高也有望在未來幾年推動市場增長。 此外，對用於進行各種調查的人性化動物模型的需求不斷增長，預計將為未來幾年的市場增長創造有利可圖的機會。 此外，許多活躍於基因毒性測試行業的公司在市場上的存在預計將在預測期內推動市場增長。 此外，全球越來越多的老年人易患各種類型的慢性病，□□這將進一步增加對遺傳毒性測試的需求，預計這將推動市場增長到 2028 年。 此外，預計在預測期內，遺傳毒性測試在食品、化妝品和藥品等各種最終用戶行業的應用越來越多，將支持遺傳毒性測試市場。 藥物開發和發現活動的增加進一步推動了市場的增長。 此外，藥物基因組學的日益普及有望在未來幾年為市場增長創造有利可圖的機會。 此外，新興國家越來越多地採用先進技術，預計將進一步增加對遺傳毒性測試的需求並支持市場的增長。 2015 年，42% 的在研藥物有可能成為個性化藥物，美國 73% 的抗癌藥物有可能成為個性化藥物。

對個性化醫療的需求不斷增長

在預測期內，對治療各種疾病的個性化醫療需求不斷增長，預計將推動市場增長。 分子醫學的進步催生了藥物基因組學的新概念，使個性化醫療能夠提供更好的藥物選擇和靶向治療。 此外，它有助於減少副作用並改善患者體驗。 在藥物開發的早期階段增加研發投入，有望在藥物達到高成本臨床階段之前增加體內毒理學方法的使用。 這將增加對基因毒理學服務的需求。 對於許多轉基因食品、藥品、化學品、殺蟲劑和疫苗，一些國家的政府要求將毒性測試作為進出口的先決條件。 2006 年至 2010 年間，美國報告稱對個性化醫療的投資增加了 73%。

啟動研發活動

隨著各種候選藥物獲得批准以及臨床前化合物的接受度不斷提高，預計基因毒性測試市場將在未來幾年不斷增長。 在藥物開發的早期階段進行密集的研究和開發活動，以實現藥物發現的主要目標。 因此，預計在預測期內對遺傳毒性測試服務的需求將會增加。 活躍於食品、化妝品和醫療保健領域的各種公司都在採用基因毒理學，導致對基因毒理學服務的需求增加，並推動了市場的增長。 2020 年聯邦政府醫療保健支出增長 36.0%，遠高於 2019 年 5.9% 的增幅。

市場細分

營銷人員

Thermo Fisher Scientific, Inc.、Eurofins Scientific SE、Jubilant Life Sciences Limited、Syngene International Limited、Gentronix Ltd.、Inotiv Inc.、Charles River Laboratories International, Inc.、Merck KGaA、Toxikon Corporation、Gentronix Limited 的示例基因毒性測試市場的主要參與者。

近期發展

  • Innotive Inc. 於 2022 年 7 月宣布，它將繼續擴大其執行體外細胞遺傳學和細菌檢測的遺傳毒性測試的能力。 這將有助於支持新治療藥物的開發。
  • 2021 年 11 月，總部位於英國的合同研究組織 Gentronix 宣布籌集了約 743,000 美元（700 歐元），以加強其眼睛、遺傳和皮膚毒性測試能力並擴建其實驗室設施。

研究範圍：

本報告將全球基因毒性檢測市場分為以下幾類，並詳細介紹了行業趨勢：

基因毒性測試市場，按成分分類：

  • 試劑和耗材
  • 化驗
  • 服務詳情

基因毒性測試市場，按類型：

  • 體外
  • 體內

基因毒性測試市場，按應用分類：

  • 製藥/生物技術
  • 化妝品
  • 食物
  • 其他

按地區劃分的遺傳毒性檢測市場：

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥倫比亞
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿聯酋
    • 埃及
    • 土耳其人

競爭格局

公司概況：對全球遺傳毒性測試市場主要參與者的深入分析。

可自定義：

根據市場數據，TechSci Research 根據公司的具體需求提供定制服務。 該報告可以定制為：

公司信息

  • 對其他市場參與者（最多 5 家公司）進行深入分析和概況分析

內容

第 1 章概述

  • 市場定義
  • 市場範圍
    • 目標市場
    • 調查年份
    • 主要市場細分

第二章研究方法論

  • 調查目的
  • 基線調查方法
  • 主要行業合作夥伴
  • 主要協會和次要信息
  • 調查方法
  • 數據三角測量和驗證
  • 假設和限制

第 3 章執行摘要

  • 市場概覽
  • 主要市場細分概述
  • 主要市場參與者概覽
  • 主要地區/國家概覽
  • 市場驅動因素、挑戰和趨勢概述

第 4 章 VOC（客戶之聲）

第 5 章基因毒性測試的全球市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按組成部分（試劑/耗材、化驗、服務）
    • 按類型（體外與體內）
    • 按應用（製藥/生物技術、化妝品、食品、其他）
    • 按地區
    • 按公司分類（2022 年）
  • 市場地圖
    • 按組件
    • 按類型
    • 通過申請
    • 按地區

第6章北美基因毒性檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按組件
    • 按類型
    • 通過申請
    • 按國家
  • 北美：國家/地區分析
    • 美國
    • 加拿大
    • 墨西哥

第7章歐洲遺傳毒性檢測市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按組件
    • 按類型
    • 通過申請
    • 按國家
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 意大利
    • 西班牙

第八章亞太地區基因毒性檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按組件
    • 按類型
    • 通過申請
    • 按國家
  • 亞太地區：國家/地區分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳大利亞

第9章南美基因毒性檢測市場展望

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按組件
    • 按類型
    • 通過申請
    • 按國家
  • 南美洲：：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章中東和非洲基因毒性檢測市場前景

  • 市場規模和預測
    • 按價值觀
  • 市場份額和預測
    • 按組件
    • 按類型
    • 通過申請
    • 按國家
  • MEA：國家分析
    • 南非遺傳毒性試驗
    • 沙特阿拉伯遺傳毒性試驗
    • 阿聯酋遺傳毒性試驗
    • 埃及遺傳毒性試驗
    • Turkiye 遺傳毒性試驗

第 11 章市場動態

  • 司機
  • 任務

第12章市場趨勢與發展

  • 近期趨勢
  • 併購
  • 產品發布

第13章競爭格局

  • Business Overview
  • Product Offerings
  • Recent Developments
  • Financials（As Reported）
  • Key Personnel
  • SWOT Analysis
    • Thermo Fisher Scientific, Inc.
    • Eurofins Scientific SE
    • Jubilant Life Sciences Limited
    • Syngene International Limited
    • Gentronix Ltd.
    • Inotiv Inc.
    • Charles River Laboratories International, Inc.
    • Merck KGaA
    • Toxikon Corporation
    • Gentronix Limited

第14章 戰略建議

簡介目錄
Product Code: 14592

Global genetic toxicology testing market is anticipated to witness impressive growth during the forecast period. This can be ascribed to the growing focus on drug discovery, and the development of new treatments or therapies for various diseases. Additionally, the growing use of personalized medicine in various in vitro procedures is expected to drive market growth in the coming years. Besides, the increasing demand for humanized animal models for conducting different research is expected to create lucrative opportunities for market growth in the coming years. Additionally, the presence of numerous players operating in the market working in the genetic toxicology testing industry is expected to drive market growth in the forecast period. Additionally, the growing geriatric population across the globe which is susceptible to different kinds of chronic diseases is further expected to increase the demand for genetic toxicology testing, thereby fuelling the market growth through 2028. Besides, the growing application of genetic toxicology testing across various end-user industries including food, cosmetics, and pharmaceutical, among others is expected to support the genetic toxicology testing market during the forecast period. The increasing drug development and discovery activities are further supporting the market growth. Also, the rising popularity of pharmacogenomics is expected to create lucrative opportunities for market growth in the coming years. Furthermore, the increasing adoption of advanced technology in emerging countries is further expected to increase the demand for genetic toxicology testing, thereby supporting market growth. In 2015, 42 percent of all drugs, in development, had the potential to be personalized medicines, while 73 percent of oncology drugs had the potential to be personalized medicines in the United States.

Growing Demand for Personalized Medicine

Increasing demand for personalized medicine for the treatment of different diseases is expected to propel market growth in the forecast period. The advancement of molecular medicine has resulted in the novel concept of pharmacogenomics where personalized medicine can provide better medication selection and targeted therapy. Additionally, it helps to reduce the side effects along with improving patient experience. Increasing research and development investments in the early stages of drug development are also expected to increase the utilization of in-vivo toxicology techniques before the drug reaches the high-cost clinical stages. This increases the demand for genetic toxicology services. For many genetically modified food, drugs, chemicals, pesticides, and vaccines, several countries' government requires toxicology testing as a pre-requisite for imports and exports. Between 2006 and 2010, investment in personalized medicine in the United States grew by 73 percent, as per reports.

Increasing R&D activities

Increasing the approval of various drug candidates and increasing acceptance of compounds in the preclinical stages is expected to grow the genetic toxicology testing market over the years. To achieve the main goal of drug discovery, intensive research, and development activities are conducted in the early stages of drug development. This, in turn, enhances the demand for genetic toxicology services in the forecast period. Different companies operating in the food, cosmetic, and healthcare sector are adopting genetic toxicology leading to a rise in demand for genetic toxicology services, thereby fuelling the growth of the market. Federal government spending for health care grew 36.0% in 2020, significantly faster than the 5.9% growth in 2019.

Market Segmentation

Global genetic toxicology testing market can be segmented by component, type, application, and by region. Based on components, the market can be segmented into Reagents & Consumables, Assays, and Services. Based on type, the market can be divided into In Vitro and In Vivo. Based on application, the market can be grouped into Pharmaceutical & Biotechnology, Cosmetics, Food, and Others. Regionally, North America dominated the market among Asia Pacific, Europe, the Middle East & Africa, and South America. Among the different countries, the United States dominated the global genetic toxicology testing market, on account of the growing demand for personalized medicine and increasing investment in the healthcare industry in the country.

Market Players

Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Jubilant Life Sciences Limited, Syngene International Limited, Gentronix Ltd., Inotiv Inc., Charles River Laboratories International, Inc., Merck KGaA, Toxikon Corporation, Gentronix Limited are some of the leading players operating in the Global Genetic Toxicology Testing Market.

Recent Developments

  • Inotiv, Inc. in July 2022 announced that it would be continuing to expand its capacity to conduct genetic toxicology studies for in vitro cytogenetics and bacterial assays. This will help in supporting the development of novel therapeutics.
  • In November 2021, United Kingdom based contract research organization, Gentronix announced that they have raised around USD 743,000(Euro 700) for the expansion of its lab facilities by enhancing its capacity for ocular, genetic, and skin toxicology testing.

Report Scope:

In this report, global genetic toxicology testing market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Genetic Toxicology Testing Market, By Component:

  • Reagents & Consumables
  • Assays
  • Services

Genetic Toxicology Testing Market, By Type:

  • In Vitro
  • In Vivo

Genetic Toxicology Testing Market, By Application:

  • Pharmaceutical & Biotechnology
  • Cosmetics
  • Food
  • Others

Genetic Toxicology Testing Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • United Kingdom
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Australia
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Turkey

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Genetic Toxicology Testing Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Genetic Toxicology Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Component (Reagents & Consumables, Assays, Services)
    • 5.2.2. By Type (In Vitro v/s In Vivo)
    • 5.2.3. By Application (Pharmaceutical & Biotechnology, Cosmetics, Food, Others)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map
    • 5.3.1. By Component
    • 5.3.2. By Type
    • 5.3.3. By Application
    • 5.3.4. By Region

6. North America Genetic Toxicology Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Component
    • 6.2.2. By Type
    • 6.2.3. By Application
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Genetic Toxicology Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Component
        • 6.3.1.2.2. By Type
        • 6.3.1.2.3. By Application
    • 6.3.2. Canada Genetic Toxicology Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Component
        • 6.3.2.2.2. By Type
        • 6.3.2.2.3. By Application
    • 6.3.3. Mexico Genetic Toxicology Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Component
        • 6.3.3.2.2. By Type
        • 6.3.3.2.3. By Application

7. Europe Genetic Toxicology Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Component
    • 7.2.2. By Type
    • 7.2.3. By Application
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Genetic Toxicology Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Component
        • 7.3.1.2.2. By Type
        • 7.3.1.2.3. By Application
    • 7.3.2. Germany Genetic Toxicology Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Component
        • 7.3.2.2.2. By Type
        • 7.3.2.2.3. By Application
    • 7.3.3. United Kingdom Genetic Toxicology Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Component
        • 7.3.3.2.2. By Type
        • 7.3.3.2.3. By Application
    • 7.3.4. Italy Genetic Toxicology Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Component
        • 7.3.4.2.2. By Type
        • 7.3.4.2.3. By Application
    • 7.3.5. Spain Genetic Toxicology Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Component
        • 7.3.5.2.2. By Type
        • 7.3.5.2.3. By Application

8. Asia-Pacific Genetic Toxicology Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Component
    • 8.2.2. By Type
    • 8.2.3. By Application
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Genetic Toxicology Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Component
        • 8.3.1.2.2. By Type
        • 8.3.1.2.3. By Application
    • 8.3.2. India Genetic Toxicology Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Component
        • 8.3.2.2.2. By Type
        • 8.3.2.2.3. By Application
    • 8.3.3. Japan Genetic Toxicology Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Component
        • 8.3.3.2.2. By Type
        • 8.3.3.2.3. By Application
    • 8.3.4. South Korea Genetic Toxicology Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Component
        • 8.3.4.2.2. By Type
        • 8.3.4.2.3. By Application
    • 8.3.5. Australia Genetic Toxicology Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Component
        • 8.3.5.2.2. By Type
        • 8.3.5.2.3. By Application

9. South America Genetic Toxicology Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Component
    • 9.2.2. By Type
    • 9.2.3. By Application
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Genetic Toxicology Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Component
        • 9.3.1.2.2. By Type
        • 9.3.1.2.3. By Application
    • 9.3.2. Argentina Genetic Toxicology Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Component
        • 9.3.2.2.2. By Type
        • 9.3.2.2.3. By Application
    • 9.3.3. Colombia Genetic Toxicology Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Component
        • 9.3.3.2.2. By Type
        • 9.3.3.2.3. By Application

10. Middle East and Africa Genetic Toxicology Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Component
    • 10.2.2. By Type
    • 10.2.3. By Application
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Genetic Toxicology Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Component
        • 10.3.1.2.2. By Type
        • 10.3.1.2.3. By Application
    • 10.3.2. Saudi Arabia Genetic Toxicology Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Component
        • 10.3.2.2.2. By Type
        • 10.3.2.2.3. By Application
    • 10.3.3. UAE Genetic Toxicology Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Component
        • 10.3.3.2.2. By Type
        • 10.3.3.2.3. By Application
    • 10.3.4. Egypt Genetic Toxicology Testing Market Outlook
      • 10.3.4.1. Market Size & Forecast
        • 10.3.4.1.1. By Value
      • 10.3.4.2. Market Share & Forecast
        • 10.3.4.2.1. By Component
        • 10.3.4.2.2. By Type
        • 10.3.4.2.3. By Application
    • 10.3.5. Turkey Genetic Toxicology Testing Market Outlook
      • 10.3.5.1. Market Size & Forecast
        • 10.3.5.1.1. By Value
      • 10.3.5.2. Market Share & Forecast
        • 10.3.5.2.1. By Component
        • 10.3.5.2.2. By Type
        • 10.3.5.2.3. By Application

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Developments
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Business Overview
  • 13.2. Product Offerings
  • 13.3. Recent Developments
  • 13.4. Financials (As Reported)
  • 13.5. Key Personnel
  • 13.6. SWOT Analysis
    • 13.6.1. Thermo Fisher Scientific, Inc.
    • 13.6.2. Eurofins Scientific SE
    • 13.6.3. Jubilant Life Sciences Limited
    • 13.6.4. Syngene International Limited
    • 13.6.5. Gentronix Ltd.
    • 13.6.6. Inotiv Inc.
    • 13.6.7. Charles River Laboratories International, Inc.
    • 13.6.8. Merck KGaA
    • 13.6.9. Toxikon Corporation
    • 13.6.10. Gentronix Limited

14. Strategic Recommendations